Imami
M
et al. Comparison of
cabergoline versus
raloxifene add-on therapy to long-acting somatostatin analogue in patients with inadequately controlled acromegaly: a randomized open label clinical trial. Endocr Pract. 2018 Jun;24(6):542–7.
[PubMed: 29949429]